DelistingOct 16, 2026, 04:36 PM
Lucid Diagnostics Faces Nasdaq Delisting Warning Over Low Stock Price
AI Summary
Lucid Diagnostics Inc. (LUCD) received a notification from Nasdaq indicating its common stock has fallen below the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company has 180 days, until April 12, 2027, to regain compliance by achieving a closing bid price of at least $1 for ten consecutive business days. While the notification does not immediately impact trading, Lucid Diagnostics intends to explore options to meet the listing standards.
Key Highlights
- Lucid Diagnostics Inc. received a Nasdaq notice for failing to maintain a minimum bid price of $1 per share.
- The company has 180 days, until April 12, 2027, to regain compliance.
- Compliance requires the stock to close at $1 or higher for ten consecutive business days.
- The Nasdaq notification does not currently affect the trading of LUCD stock.
Price Impact
More from LUCD